PAMU
CYTK icon

Pictet Asset Management (UK)’s Cytokinetics CYTK Stock Holding History

Pictet Asset Management (UK)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$8.06M Sell
407,469
-12,384
-3% -$291K 0.01% 735
2021
Q1 		$9.77M Hold
419,853
– – 0.01% 665
2020
Q4 		$8.72M Buy
+419,853
New +$7.67M 0.01% 664

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Pictet Asset Management (UK)'s CYTK Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Cytokinetics (CYTK) stake by 2.9% in Q2 2021, selling an estimated $291K and leaving 407,469 shares worth $8.06M. The position accounts for 0.01% of the portfolio, ranked #735.

Pictet Asset Management (UK) first reported a position in CYTK in Q4 2020 and has held it in 3 quarters since. The position peaked at $9.77M in Q1 2021. 190 funds tracked by Wall St. Rank hold CYTK as of Q2 2021.

  • Pictet Asset Management (UK) held 407,469 shares of Cytokinetics worth $8.06M as of Q2 2021.
  • Pictet Asset Management (UK) sold 12,384 Cytokinetics shares in Q2 2021, an estimated $291K.
  • Cytokinetics made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #735 holding.
  • Pictet Asset Management (UK) first reported a position in Cytokinetics in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s Cytokinetics position peaked at $9.77M in Q1 2021.
  • 190 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.